Counterpoint: Evidence-Based Prevention of Type 2 Diabetes: The Power of Lifestyle Management
Open Access
- 1 February 2007
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (2) , 435-438
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Effect of Ramipril on the Incidence of DiabetesNew England Journal of Medicine, 2006
- Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trialThe Lancet, 2006
- Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 DiabetesJACC, 2005
- Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT malesDiabetes Research and Clinical Practice, 2005
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Primary Prevention of Diabetes MellitusDiabetes Care, 1987
- Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulationDiabetes, 1980
- THE PREVENTION OF DIABETES MELLITUSJAMA, 1921